Logos Global Management’s Tyra Biosciences TYRA Stock Holding History

Logos Global Management’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-850,000	Closed	-$32.6M	–	89
2026 Q1	$32.6M	Buy	850,000 +640,000	+305%	+$20.7M	1.63%	21
2025 Q4	$5.52M	Buy	+210,000	New	+$3.86M	0.33%	51
2023 Q4	–	Sell	-31,872	Closed	-$439K	–	70
2023 Q3	$439K	Hold	31,872	–	–	0.06%	54
2023 Q2	$543K	Sell	31,872 -55,801	-64%	-$809K	0.07%	50
2023 Q1	$1.41M	Sell	87,673 -23,183	-21%	-$276K	0.2%	39
2022 Q4	$843K	Sell	110,856 -16,460	-13%	-$116K	0.1%	38
2022 Q3	$1.12M	Sell	127,316 -39,210	-24%	-$359K	0.14%	35
2022 Q2	$1.19M	Sell	166,526 -86,200	-34%	-$686K	0.22%	26
2022 Q1	$2.7M	Sell	252,726 -220,668	-47%	-$2.62M	0.35%	30
2021 Q4	$6.66M	Sell	473,394 -530,000	-53%	-$10.5M	0.69%	33
2021 Q3	$17.6M	Buy	+1,003,394	New	+$19.2M	1.27%	25

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Logos Global Management's TYRA Position: Q2 2026 in Review

Logos Global Management sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 850,000 shares — an estimated $32.6M sold.

Logos Global Management first reported a position in TYRA in Q3 2021 and held it in 11 quarters. The position peaked at $32.6M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Logos Global Management reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
Logos Global Management sold 850,000 Tyra Biosciences shares in Q2 2026, an estimated $32.6M.
Logos Global Management first reported a position in Tyra Biosciences in Q3 2021 and held it in 11 quarters.
Logos Global Management's Tyra Biosciences position peaked at $32.6M in Q1 2026.
169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.